Industry News Update - Dec 18

Roche and Genentech have committed up to $12 Billion to Recursion to use their OS in a major AI Drug Discovery collaboration.

• Headline: 
• Founders: 
• The science: 
• The technology: 
• Future plans
• Other notes:
• Customer segment
• Who pays?
• Competition
• Analysis

EQRx Debuts as Publicly Traded Company to Develop and Deliver Innovative Medicines at Radically Lower Prices

• Headline: 
• Founders: 
• The science: 
• The technology: 
• Future plans
• Other notes:
• Customer segment
• Who pays?
• Competition
• Analysis

Innovaccer Raises $150 Million Series E Round at $3.2 Billion Valuation, Continues Rapid Growth Trajectory

• Headline: 
• Founders: 
• The science: 
• The technology: 
• Future plans
• Other notes:
• Customer segment
• Who pays?
• Competition
• Analysis

Cadence raised a Series B round of funding to scale its remote care platform with the leading national health systems. 

• Headline: Their vision is to bring more responsive, personalized, and data-driven care to patients in the comfort of their own homes. 
• Founders: 
• The science: 
• The technology: 
• Future plans
• Other notes:
• Customer segment
• Who pays?
• Competition
• Analysis